116 related articles for article (PubMed ID: 8157723)
1. Impaired renal 11 beta-oxidation of 9 alpha-fluorocortisol: an explanation for its mineralocorticoid potency.
Oelkers W; Buchen S; Diederich S; Krain J; Muhme S; Schöneshöfer M
J Clin Endocrinol Metab; 1994 Apr; 78(4):928-32. PubMed ID: 8157723
[TBL] [Abstract][Full Text] [Related]
2. The metabolism of 9 alpha-fluorinated steroids in the human kidney.
Diederich S; Hanke B; Bähr V; Oelkers W
Endocr Res; 1996 Nov; 22(4):803-10. PubMed ID: 8969943
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of synthetic corticosteroids by 11 beta-hydroxysteroid-dehydrogenases in man.
Diederich S; Hanke B; Burkhardt P; Müller M; Schöneshöfer M; Bähr V; Oelkers W
Steroids; 1998; 63(5-6):271-7. PubMed ID: 9618784
[TBL] [Abstract][Full Text] [Related]
4. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
5. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
Edwards CR; Stewart PM
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
[TBL] [Abstract][Full Text] [Related]
6. The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.
Monder C; Shackleton CH; Bradlow HL; New MI; Stoner E; Iohan F; Lakshmi V
J Clin Endocrinol Metab; 1986 Sep; 63(3):550-7. PubMed ID: 3460996
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycyrrhizin on cortisol metabolism in humans.
Soma R; Ikeda M; Morise T; Miyamori I; Takeda R
Endocr Regul; 1994 Mar; 28(1):31-4. PubMed ID: 7949011
[TBL] [Abstract][Full Text] [Related]
8. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
[TBL] [Abstract][Full Text] [Related]
9. RU-26988--a new tool for the study of the mineralocorticoid receptor.
Gomez-Sanchez CE; Gomez-Sanchez EP
Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
[TBL] [Abstract][Full Text] [Related]
10. Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.
Montrella-Waybill M; Clore JN; Schoolwerth AC; Watlington CO
J Clin Endocrinol Metab; 1991 May; 72(5):1060-6. PubMed ID: 1850752
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction.
Diederich S; Hanke B; Oelkers W; Bähr V
J Clin Endocrinol Metab; 1997 May; 82(5):1598-602. PubMed ID: 9141556
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney.
Kageyama Y; Suzuki H; Saruta T
J Endocrinol; 1992 Oct; 135(1):147-52. PubMed ID: 1431677
[TBL] [Abstract][Full Text] [Related]
13. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
14. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
Quinkler M; Meyer B; Oelkers W; Diederich S
J Clin Endocrinol Metab; 2003 Aug; 88(8):3767-72. PubMed ID: 12915667
[TBL] [Abstract][Full Text] [Related]
15. 11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action.
Benediktsson R; Edwards CR
Essays Biochem; 1996; 31():23-36. PubMed ID: 9078455
[TBL] [Abstract][Full Text] [Related]
16. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
Finken MJ; Andrews RC; Andrew R; Walker BR
J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
[TBL] [Abstract][Full Text] [Related]
17. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
Rodríguez JA
Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
[TBL] [Abstract][Full Text] [Related]
18. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
Ulick S; Wang JZ; Hanukoglu A; Rösler A
J Lab Clin Med; 1993 Dec; 122(6):673-6. PubMed ID: 8245686
[TBL] [Abstract][Full Text] [Related]
19. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
[TBL] [Abstract][Full Text] [Related]
20. Apparent mineralocorticoid excess.
Benediktsson R; Edwards CR
J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
